<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34115105</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>144</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>16</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>TDP-43 stabilizes G3BP1 mRNA: relevance to amyotrophic lateral sclerosis/frontotemporal dementia.</ArticleTitle><Pagination><StartPage>3461</StartPage><EndPage>3476</EndPage><MedlinePgn>3461-3476</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awab217</ELocationID><Abstract><AbstractText>TDP-43 nuclear depletion and concurrent cytoplasmic accumulation in vulnerable neurons is a hallmark feature of progressive neurodegenerative proteinopathies such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Cellular stress signalling and stress granule dynamics are now recognized to play a role in ALS/FTD pathogenesis. Defective stress granule assembly is associated with increased cellular vulnerability and death. Ras-GAP SH3-domain-binding protein 1 (G3BP1) is a critical stress granule assembly factor. Here, we define that TDP-43 stabilizes G3BP1 transcripts via direct binding of a highly conserved cis regulatory element within the 3' untranslated region. Moreover, we show in vitro and in vivo that nuclear TDP-43 depletion is sufficient to reduce G3BP1 protein levels. Finally, we establish that G3BP1 transcripts are reduced in ALS/FTD patient neurons bearing TDP-43 cytoplasmic inclusions/nuclear depletion. Thus, our data indicate that, in ALS/FTD, there is a compromised stress granule response in disease-affected neurons due to impaired G3BP1 mRNA stability caused by TDP-43 nuclear depletion. These data implicate TDP-43 and G3BP1 loss of function as contributors to disease.</AbstractText><CopyrightInformation>&#xa9; The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sidib&#xe9;</LastName><ForeName>Hadjara</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3A 0E8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHUM Research Center, Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalfallah</LastName><ForeName>Yousra</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CHUM Research Center, Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3A 0E8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Shangxi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON M5T 0S8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez</LastName><ForeName>Nicol&#xe1;s B</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fakim</LastName><ForeName>Hana</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3A 0E8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHUM Research Center, Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tank</LastName><ForeName>Elizabeth M H</ForeName><Initials>EMH</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Tomasso</LastName><ForeName>Genevi&#xe8;ve</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3A 0E8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bareke</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>CHUM Research Center, Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aulas</LastName><ForeName>Ana&#xef;s</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHUM Research Center, Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3A 0E8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKeever</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0002-9464-141X</Identifier><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON M5T 0S8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melamed</LastName><ForeName>Ze'ev</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>University of California, San Diego/Ludwig Institute for Cancer Research, San Diego, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Destroimaisons</LastName><ForeName>Laurie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CHUM Research Center, Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deshaies</LastName><ForeName>Jade-Emmanuelle</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>CHUM Research Center, Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zinman</LastName><ForeName>Lorne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON M4N 3M5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>J Alex</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3A 0E8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHUM Research Center, Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legault</LastName><ForeName>Pascale</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-1782-5204</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3A 0E8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T&#xe9;treault</LastName><ForeName>Martine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3A 0E8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHUM Research Center, Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barmada</LastName><ForeName>Sami J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0002-9604-968X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI 48109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>Janice</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON M5T 0S8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vande Velde</LastName><ForeName>Christine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5926-1529</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, QC H3A 0E8, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHUM Research Center, Montr&#xe9;al, QC H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG053760</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS097542</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072931</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS113943</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007315</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075223">Poly-ADP-Ribose Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067776">RNA Recognition Motif Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.12</RegistryNumber><NameOfSubstance UI="C116070">G3BP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D020365">RNA Helicases</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004265" MajorTopicYN="N">DNA Helicases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075223" MajorTopicYN="N">Poly-ADP-Ribose Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020365" MajorTopicYN="N">RNA Helicases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067776" MajorTopicYN="N">RNA Recognition Motif Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">G3BP1</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">stress granules</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>11</Day><Hour>12</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34115105</ArticleId><ArticleId IdType="pmc">PMC8677511</ArticleId><ArticleId IdType="doi">10.1093/brain/awab217</ArticleId><ArticleId IdType="pii">6296831</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW.. Decoding ALS: From genes to mechanism. Nature. 2016;539(7628):197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo PH, Chiang CH, Wang YT, Doudeva LG, Yuan HS.. The crystal structure of TDP-43 RRM1-DNA complex reveals the specific recognition for UG- and TG-rich nucleic acids. Nucleic Acids Res. 2014;42(7):4712&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3985631</ArticleId><ArticleId IdType="pubmed">24464995</ArticleId></ArticleIdList></Reference><Reference><Citation>Mompean M, Romano V, Pantoja-Uceda D, et al.The TDP-43 N-terminal domain structure at high resolution. Febs J. 2016;283(7):1242&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">26756435</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T, Hock E-M, Ernst P, et al.Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat Commun. 2017;8(1):45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, et al.Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman MS, Trojanowski JQ, Lee VMY.. TDP-43: A novel neurodegenerative proteinopathy. Curr Opin Neurobiol. 2007;17(5):548&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2678676</ArticleId><ArticleId IdType="pubmed">17936612</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O.. The epidemiology of ALS: A conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9(11):617&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Nicholson AM, Sarkar M, et al.TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron. 2017;95(4):808&#x2013;816.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Bogaert E, Kovacs D, et al.Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics. Mol Cell. 2017;65(6):1044&#x2013;1055.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5364369</ArticleId><ArticleId IdType="pubmed">28306503</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey CM, Cenik B, Sephton CF, et al.TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. MolCell Biol. 2010;31(5):1098&#x2013;1108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3067820</ArticleId><ArticleId IdType="pubmed">21173160</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidib&#xe9; H, Vande Velde C.. RNA granules and their role in neurodegenerative diseases. In: Oeffinger M, Zenklusen D, eds. The biology of mRNA: structure and function. Springer International Publishing; 2019:195&#x2013;245.</Citation></Reference><Reference><Citation>Anderson P, Kedersha N.. RNA granules. J Cell Biol. 2006;172(6):803&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2063724</ArticleId><ArticleId IdType="pubmed">16520386</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson P, Kedersha N.. Stress granules: The Tao of RNA triage. Trends Biochem Sci. 2008;33(3):141&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">18291657</ArticleId></ArticleIdList></Reference><Reference><Citation>Tourriere H, Chebli K, Zekri L, et al.The RasGAP-associated endoribonuclease G3BP assembles stress granules. J Cell Biol. 2003;160(6):823&#x2013;831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2173781</ArticleId><ArticleId IdType="pubmed">12642610</ArticleId></ArticleIdList></Reference><Reference><Citation>Humoud MN, Doyle N, Royall E, et al.Feline calicivirus infection disrupts assembly of cytoplasmic stress granules and induces G3BP1 cleavage. J Virol. 2016;90(14):6489&#x2013;6501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4936126</ArticleId><ArticleId IdType="pubmed">27147742</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald KK, Aulas A, Destroismaisons L, et al.TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum Mol Genet. 2011;20(7):1400&#x2013;1410.</Citation><ArticleIdList><ArticleId IdType="pubmed">21257637</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A, Caron G, Gkogkas CG, et al.G3BP1 promotes stress-induced RNA granule interactions to preserve polyadenylated mRNA. J Cell Biol. 2015;209(1):73&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4395486</ArticleId><ArticleId IdType="pubmed">25847539</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A, Stabile S, Vande Velde C.. Endogenous TDP-43, but not FUS, contributes to stress granule assembly via G3BP. Mol Neurodegener. 2012;7:54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3502460</ArticleId><ArticleId IdType="pubmed">23092511</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalfallah Y, Kuta R, Grasmuck C, Prat A, Durham HD, Vande Velde C.. TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types. Sci Rep. 2018;8(1):7551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5953947</ArticleId><ArticleId IdType="pubmed">29765078</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P, Mathieu C, Kolaitis R-M, et al.G3BP1 is a tunable switch that triggers phase separation to assemble stress granules. Cell. 2020;181(2):325&#x2013;345.e28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7448383</ArticleId><ArticleId IdType="pubmed">32302571</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders DW, Kedersha N, Lee DSW, et al.Competing protein-RNA interaction networks control multiphase intracellular organization. Cell. 2020;181(2):306&#x2013;324.e28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816278</ArticleId><ArticleId IdType="pubmed">32302570</ArticleId></ArticleIdList></Reference><Reference><Citation>Guill&#xe9;n-Boixet J, Kopach A, Holehouse AS, et al.RNA-induced conformational switching and clustering of G3BP drive stress granule assembly by condensation. Cell. /2020;181(2):346&#x2013;361.e17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7181197</ArticleId><ArticleId IdType="pubmed">32302572</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Lin L, Tradewell ML, et al.Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet. 2010;19(4):671&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pubmed">19959528</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VM.. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J Biol Chem. 2008;283(19):13302&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshaies JE, Shkreta L, Moszczynski AJ, et al.TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis. Brain. 2018;141(5):1320&#x2013;1333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5917749</ArticleId><ArticleId IdType="pubmed">29562314</ArticleId></ArticleIdList></Reference><Reference><Citation>Tank EM, Figueroa-Romero C, Hinder LM, et al.Abnormal RNA stability in amyotrophic lateral sclerosis. Nat Commun. 2018;9(1):2845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6054632</ArticleId><ArticleId IdType="pubmed">30030424</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Chau KF, Vodyanik MA, Jiang J, Jiang Y.. Efficient feeder-free episomal reprogramming with small molecules. PLoS ONE. 2011;6(3):e17557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3046978</ArticleId><ArticleId IdType="pubmed">21390254</ArticleId></ArticleIdList></Reference><Reference><Citation>Busskamp V, Lewis NE, Guye P, et al.Rapid neurogenesis through transcriptional activation in human stem cells. Mol Syst Biol. 2014;10:760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4299601</ArticleId><ArticleId IdType="pubmed">25403753</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam RS, Topfer FM, Wood PG, Busskamp V, Bamberg E.. Functional maturation of human stem cell-derived neurons in long-term cultures. PLoS ONE. 2017;12(1):e0169506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5215418</ArticleId><ArticleId IdType="pubmed">28052116</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandopulle MS, Prestil R, Grunseich C, Wang C, Gan L, Ward ME.. Transcription factor-mediated differentiation of human iPSCs into neurons. Curr Protoc Cell Biol. 2018;79(1):e51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6993937</ArticleId><ArticleId IdType="pubmed">29924488</ArticleId></ArticleIdList></Reference><Reference><Citation>Weskamp K, Tank EM, Miguez R, et al.Neuronal hyperexcitability drives TDP43 pathology by upregulating shortened TDP43 protein isoforms. 2019:648477.</Citation></Reference><Reference><Citation>Cerbini T, Funahashi R, Luo Y, et al.Transcription activator-like effector nuclease (TALEN)-mediated CLYBL targeting enables enhanced transgene expression and one-step generation of dual reporter human induced pluripotent stem cell (iPSC) and neural stem cell (NSC) lines. PLoS ONE. 2015;10(1):e0116032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4294658</ArticleId><ArticleId IdType="pubmed">25587899</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman S, Zorca CE, Traboulsi T, et al.Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription. Nucleic Acids Res. 2017;45(6):3017&#x2013;3030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5389544</ArticleId><ArticleId IdType="pubmed">27932455</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolte S, Cordeli&#xe8;res FP.. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc. 2006;224(Pt 3):213&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">17210054</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvail-Lacoste A, Di Tomasso G, Piette BL, Legault P.. Affinity purification of T7 RNA transcripts with homogeneous ends using ARiBo and CRISPR tags. RNA (New York, NY). 2013;19(7):1003&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3683919</ArticleId><ArticleId IdType="pubmed">23657939</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Tomasso G, Lampron P, Dagenais P, Omichinski JG, Legault P.. The ARiBo tag: A reliable tool for affinity purification of RNAs under native conditions. Nucleic Acids Res. 2011;39(3):e18&#x2013;e18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3035436</ArticleId><ArticleId IdType="pubmed">21071425</ArticleId></ArticleIdList></Reference><Reference><Citation>Moisse K, Volkening K, Leystra-Lantz C, Welch I, Hill T, Strong MJ.. Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: Implications for TDP-43 in the physiological response to neuronal injury. Brain Res. 2009;1249:202&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">19046946</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez A, Perez-Gracia E, Espinosa JC, Pumarola M, Torres JM, Ferrer I.. Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice. Acta Neuropathol. 2006;112(5):573&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">16871401</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Belzil VV, Batra R, et al.Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat Neurosci. 2015;18(8):1175&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Paggi JM, Park C, Bennett C, Salzberg SL.. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37(8):907&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605509</ArticleId><ArticleId IdType="pubmed">31375807</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S, Pyl PT, Huber W.. HTSeq&#x2013;a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31(2):166&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4287950</ArticleId><ArticleId IdType="pubmed">25260700</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S.. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Krach F, Batra R, Wheeler EC, et al.Transcriptome-pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS. Acta Neuropathol. 2018;136(3):405&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6215775</ArticleId><ArticleId IdType="pubmed">29881994</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha KCH, Blencowe BJ, Morris Q.. QAPA: A new method for the systematic analysis of alternative polyadenylation from RNA-seq data. Genome Biol. 2018;19(1):45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5874996</ArticleId><ArticleId IdType="pubmed">29592814</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L, Bilgutay A, Zhang YJ, et al.Tar DNA binding protein-43 (TDP-43) associates with stress granules: Analysis of cultured cells and pathological brain tissue. PLoS ONE. 2010;5(10):e13250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z, Lopez-Erauskin J, Baughn MW, et al.Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nature Neurosci. 2019;22(2):180&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S, Sanelli T, Chiang H, et al.Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death. Acta Neuropathol. 2015;130(1):49&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4468798</ArticleId><ArticleId IdType="pubmed">25788357</ArticleId></ArticleIdList></Reference><Reference><Citation>Baird T, Hogg J.. Using tet-off cells and RNAi knockdown to assay mRNA decay. Methods Mol Biol. 2018:1720:161&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6309984</ArticleId><ArticleId IdType="pubmed">29236258</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukavsky PJ, Daujotyte D, Tollervey JR, et al.Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43. Nat Struct Mol Biol. 2013;20(12):1443&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24240615</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J, Wu F, Xu W, et al.TDP-43 suppresses tau expression via promoting its mRNA instability. Nucleic Acids Res. 2017;45(10):6177&#x2013;6193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5449590</ArticleId><ArticleId IdType="pubmed">28335005</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiesel FC, Voigt A, Weber SS, et al.Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J. 2010;29(1):209&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2808372</ArticleId><ArticleId IdType="pubmed">19910924</ArticleId></ArticleIdList></Reference><Reference><Citation>Paz I, Kosti I, Ares M Jr, Cline M, Mandel-Gutfreund Y.. RBPmap: A web server for mapping binding sites of RNA-binding proteins. Nucleic Acids Res. 2014;42(Web Server issue):W361&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4086114</ArticleId><ArticleId IdType="pubmed">24829458</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey TL, Boden M, Buske FA, et al.MEME SUITE: Tools for motif discovery and searching. Nucleic Acids Res. 2009;37(Web Server issue):W202&#x2013;W208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2703892</ArticleId><ArticleId IdType="pubmed">19458158</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccaro A, Tauffenberger A, Ash PE, Carlomagno Y, Petrucelli L, Parker JA.. TDP-1/TDP-43 regulates stress signaling and age-dependent proteotoxicity in Caenorhabditis elegans. PLoS Genet. 2012;8(7):e1002806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3390363</ArticleId><ArticleId IdType="pubmed">22792076</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang IF, Wu LS, Chang HY, Shen CK.. TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J Neurochem. 2008;105(3):797&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pubmed">18088371</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C, Onesto E, Megiorni F, et al.TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J Biol Chem. 2012;287(19):15635&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3346140</ArticleId><ArticleId IdType="pubmed">22427648</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui J, Hung LH, Heiner M, et al.Intronic CA&#x2010;repeat and CA&#x2010;rich elements: A new class of regulators of mammalian alternative splicing. EMBO J. 2005;24(11):1988&#x2013;1998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1142610</ArticleId><ArticleId IdType="pubmed">15889141</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE.. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem. 2001;276(39):36337&#x2013;36343.</Citation><ArticleIdList><ArticleId IdType="pubmed">11470789</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M, Ezzi SA, Julien JP.. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2007;104(7):2495&#x2013;2500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1790867</ArticleId><ArticleId IdType="pubmed">17277077</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Pak C, Han Y, et al.Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron. 2013;78(5):785&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3751803</ArticleId><ArticleId IdType="pubmed">23764284</ArticleId></ArticleIdList></Reference><Reference><Citation>Costessi L, Porro F, Iaconcig A, Muro AF.. TDP-43 regulates beta-adducin (Add2) transcript stability. RNA Biol. 2014;11(10):1280&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4615836</ArticleId><ArticleId IdType="pubmed">25602706</ArticleId></ArticleIdList></Reference><Reference><Citation>Romo L, Ashar-Patel A, Pfister E, Aronin N.. Alterations in mRNA 3' UTR isoform abundance accompany gene expression changes in human Huntington's disease brains. Cell Rep. 2017;20(13):3057&#x2013;3070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5625827</ArticleId><ArticleId IdType="pubmed">28954224</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng D, Wang R, Ding Q, et al.Cellular stress alters 3&#x2032;UTR landscape through alternative polyadenylation and isoform-specific degradation. Nat Commun. 2018;9(1):2268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5995920</ArticleId><ArticleId IdType="pubmed">29891946</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau AG, Irier HA, Gu J, et al.Distinct 3&#x2b9; UTRs differentially regulate activity-dependent translation of brain-derived neurotrophic factor (BDNF). Proc Natl Acad Sci U S A. 2010;107(36):15945&#x2013;15950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2936648</ArticleId><ArticleId IdType="pubmed">20733072</ArticleId></ArticleIdList></Reference><Reference><Citation>Tushev G, Glock C, Heumuller M, Biever A, Jovanovic M, Schuman EM.. Alternative 3' UTRs modify the localization, regulatory potential, stability, and plasticity of mRNAs in neuronal compartments. Neuron. 2018;98(3):495&#x2013;511.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">29656876</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan XC, Steitz JA.. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 1998;17(12):3448&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1170681</ArticleId><ArticleId IdType="pubmed">9628880</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR, Gleixner AM, Mauna JC, et al.RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron. 2019;102(2):321-338.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Nostrand EL, Freese P, Pratt GA, et al.A large-scale binding and functional map of human RNA-binding proteins. Nature. 2020;583(7818):711&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7410833</ArticleId><ArticleId IdType="pubmed">32728246</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S, Bellora N, Gonz&#xe1;lez-Vallinas J, et al.Preferential binding of a stable G3BP ribonucleoprotein complex to intron-retaining transcripts in mouse brain and modulation of their expression in the cerebellum. J Neurochem. 2016;139(3):349&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pubmed">27513819</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S, Zekri L, Metz A, et al.Deficiency of G3BP1, the stress granules assembly factor, results in abnormal synaptic plasticity and calcium homeostasis in neurons. J Neurochem. 2013;125(2):175&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">23373770</ArticleId></ArticleIdList></Reference><Reference><Citation>Zekri L, Chebli K, Tourriere H, et al.Control of fetal growth and neonatal survival by the RasGAP-associated endoribonuclease G3BP. Mol Cell Biol. 2005;25(19):8703&#x2013;8716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1265751</ArticleId><ArticleId IdType="pubmed">16166649</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo PK, Lee SJ, Jaiswal PB, et al.Axonal G3BP1 stress granule protein limits axonal mRNA translation and nerve regeneration. Nat Commun. 2018;9(1):3358&#x2013;3358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6105716</ArticleId><ArticleId IdType="pubmed">30135423</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd RE. Enterovirus control of translation and RNA granule stress responses. Viruses. 2016;8(4):93&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4848588</ArticleId><ArticleId IdType="pubmed">27043612</ArticleId></ArticleIdList></Reference><Reference><Citation>White JP, Cardenas AM, Marissen WE, Lloyd RE.. Inhibition of cytoplasmic mRNA stress granule formation by a viral proteinase. Cell Host Microbe. 2007;2(5):295&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">18005751</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung G, Ng CS, Zhang J, et al.Production of a dominant-negative fragment due to G3BP1 cleavage contributes to the disruption of mitochondria-associated protective stress granules during CVB3 infection. PLoS ONE. 2013;8(11):e79546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3832613</ArticleId><ArticleId IdType="pubmed">24260247</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N, Iwasaki T, Ami Y, et al.A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21. Virology. 2004;321(1):87&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">15033568</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue YC, Feuer R, Cashman N, Luo H.. Enteroviral infection: The forgotten link to amyotrophic lateral sclerosis? Front Mol Neurosci. 2018;11:63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5857577</ArticleId><ArticleId IdType="pubmed">29593492</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>